141 related articles for article (PubMed ID: 7576039)
1. Efficacy of risperidone for behavioral disorders in the elderly: a clinical observation.
Raheja RK; Bharwani I; Penetrante AE
J Geriatr Psychiatry Neurol; 1995 Jul; 8(3):159-61. PubMed ID: 7576039
[TBL] [Abstract][Full Text] [Related]
2. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
[TBL] [Abstract][Full Text] [Related]
3. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
De Deyn PP; Buitelaar J
Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
[TBL] [Abstract][Full Text] [Related]
4. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
[TBL] [Abstract][Full Text] [Related]
5. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
6. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
7. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
8. Risperidone in the management of psychiatric and neurodegenerative disease in the elderly: an update.
DeVane CL; Mintzer J
Psychopharmacol Bull; 2003; 37(4):116-32. PubMed ID: 15131522
[TBL] [Abstract][Full Text] [Related]
9. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
[TBL] [Abstract][Full Text] [Related]
10. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
Simon EW; Blubaugh KM; Pippidis M
Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of risperidone in treating the hyperactive symptoms of delirium.
Liu CY; Juang YY; Liang HY; Lin NC; Yeh EK
Int Clin Psychopharmacol; 2004 May; 19(3):165-8. PubMed ID: 15107660
[TBL] [Abstract][Full Text] [Related]
12. Liquid risperidone in the treatment of psychotic agitation.
Tsai C; Puzantian T
CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
[No Abstract] [Full Text] [Related]
13. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
[TBL] [Abstract][Full Text] [Related]
14. Prolonged delirium managed with risperidone.
Bourgeois JA; Hilty DM
Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
[No Abstract] [Full Text] [Related]
15. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
16. Management of the agitated elderly patient in the nursing home: the role of the atypical antipsychotics.
Verma SD; Davidoff DA; Kambhampati KK
J Clin Psychiatry; 1998; 59 Suppl 19():50-5. PubMed ID: 9847052
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
Kurz A; Delius-Stute H; Rettig K; Schwalen S
MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
19. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
Kurz A; Schwalen S S; Schmitt A
Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
[TBL] [Abstract][Full Text] [Related]
20. The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease.
Workman RH; Orengo CA; Bakey AA; Molinari VA; Kunik ME
J Neuropsychiatry Clin Neurosci; 1997; 9(4):594-7. PubMed ID: 9447503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
